Displaying 1 - 50 of 113 results
Released Company Title Industry Topic
13 Oct 2020
09:12 CEST
ACACIA PHARMA Director/PDMR Shareholding 20103010 Biotechnology Other subject
13 Oct 2020
09:10 CEST
ACACIA PHARMA Director/PDMR Shareholding 20103010 Biotechnology Other subject
13 Oct 2020
09:06 CEST
ACACIA PHARMA Issue of Shares to Employee Benefit Trust 20103010 Biotechnology Other subject
09 Oct 2020
07:00 CEST
ACACIA PHARMA Acacia Pharma completes drawdown from €25 million loan facility from Cosmo Pharmaceuticals to support US launches of BARHEMSYS® and BYFAVO™ 20103010 Biotechnology Other subject
06 Oct 2020
16:45 CEST
ACACIA PHARMA Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US 20103010 Biotechnology Other subject
24 Aug 2020
07:00 CEST
ACACIA PHARMA BARHEMSYS® (amisulpride injection) Launched in the US for the Treatment and Prevention of PONV 20103010 Biotechnology Other subject
19 Aug 2020
12:16 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
19 Aug 2020
12:14 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
19 Aug 2020
12:10 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
18 Aug 2020
08:01 CEST
ACACIA PHARMA Admission to Trading on Euronext Brussels 20103010 Biotechnology Other subject
14 Aug 2020
13:25 CEST
ACACIA PHARMA Publication of Prospectus 20103010 Biotechnology Other subject
14 Aug 2020
08:00 CEST
ACACIA PHARMA Results of Placing 20103010 Biotechnology Other financial transaction
13 Aug 2020
15:01 CEST
ACACIA PHARMA Proposed Capital Raising by way of a Placing of New Ordinary Shares 20103010 Biotechnology Other financial transaction
13 Aug 2020
15:00 CEST
ACACIA PHARMA Interim Results for the Six Months ended 30 June 2020 20103010 Biotechnology Other subject
27 Jul 2020
07:00 CEST
ACACIA PHARMA Acacia Pharma Advances Preparations for US Launch of BARHEMSYS® 20103010 Biotechnology Other subject
21 Jul 2020
12:43 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
21 Jul 2020
12:38 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
21 Jul 2020
12:34 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
16 Jul 2020
13:48 CEST
ACACIA PHARMA Issue of Equity pursuant to Sub-Licensing Agreement With Cosmo Technologies 20103010 Biotechnology Other subject
15 Jul 2020
07:00 CEST
ACACIA PHARMA Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV 20103010 Biotechnology Other subject
02 Jul 2020
20:02 CEST
ACACIA PHARMA Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedatio 20103010 Biotechnology Other subject
08 Jun 2020
11:01 CEST
ACACIA PHARMA TR-1: Standard form for notification of major holdings 20103010 Biotechnology Other subject
04 Jun 2020
11:03 CEST
ACACIA PHARMA TR-1: Standard form for notification of major holdings 20103010 Biotechnology Other subject
04 Jun 2020
10:59 CEST
ACACIA PHARMA TR-1: Standard form for notification of major holdings 20103010 Biotechnology Other subject
01 Jun 2020
07:00 CEST
ACACIA PHARMA Acacia Pharma Announces Debt for Equity Swap with Cosmo Pharmaceuticals 20103010 Biotechnology Other subject
08 May 2020
07:00 CEST
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Pharmaceuticals Other subject
07 May 2020
07:00 CEST
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Pharmaceuticals Other subject
07 Apr 2020
23:19 CEST
ACACIA PHARMA Alessandro Della Chà appointed as Director of Acacia Pharma Group plc Pharmaceuticals Other subject
07 Apr 2020
23:15 CEST
ACACIA PHARMA Results of Annual General Meeting Pharmaceuticals Other subject
24 Mar 2020
18:36 CET
ACACIA PHARMA Publication of Prospectus Pharmaceuticals Other subject
23 Mar 2020
10:00 CET
ACACIA PHARMA Forthcoming 2020 Annual General Meeting – Change of Venue and Proxy Forms Pharmaceuticals Other subject
16 Mar 2020
15:04 CET
ACACIA PHARMA Acacia Pharma Group plc: Notice of Annual General Meeting Pharmaceuticals Other subject
12 Mar 2020
12:52 CET
ACACIA PHARMA Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation Pharmaceuticals Other subject
09 Mar 2020
11:17 CET
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Pharmaceuticals Other subject
02 Mar 2020
07:05 CET
ACACIA PHARMA Acacia Pharma Announces Changes to its Officers and Board of Directors Pharmaceuticals Other subject
02 Mar 2020
07:00 CET
ACACIA PHARMA Acacia Pharma Group plc: Results for the year ended 31 December 2019 Pharmaceuticals Other subject
27 Feb 2020
07:10 CET
ACACIA PHARMA Acacia Pharma to Announce its Results for the Full Year 2019 on 2 March 2020 and Provides Notice of its Annual General Meeting Pharmaceuticals Other subject
27 Feb 2020
07:00 CET
ACACIA PHARMA Acacia Pharma Announces US FDA Approval of BARHEMSYS® (amisulpride) for the Treatment and Prevention of Postoperative Nausea and Vomiting (PONV) Pharmaceuticals Other subject
24 Jan 2020
09:00 CET
ACACIA PHARMA Acacia Pharma wins BEL Small Company of the Year 2019 Pharmaceuticals Other subject
15 Jan 2020
17:50 CET
ACACIA PHARMA TR-1: Standard form for notification of major holdings Pharmaceuticals Other subject
14 Jan 2020
15:26 CET
ACACIA PHARMA TR-1: Standard form for notification of major holdings Pharmaceuticals Other subject
14 Jan 2020
11:10 CET
ACACIA PHARMA TR-1: Standard form for notification of major holdings Pharmaceuticals Other subject
14 Jan 2020
11:08 CET
ACACIA PHARMA TR-1: Standard form for notification of major holdings Pharmaceuticals Other subject
13 Jan 2020
17:59 CET
ACACIA PHARMA Issue of Equity on Share Subscription and Licensing agreement With Cosmo Pharmaceuticals Pharmaceuticals Change in Capital
13 Jan 2020
07:00 CET
ACACIA PHARMA Acacia Pharma Group plc announces planned CFO succession Pharmaceuticals Other subject
10 Jan 2020
07:00 CET
ACACIA PHARMA Acacia Pharma enters into strategic in-licensing, investment and loan transaction with Cosmo Pharmaceuticals N.V. Pharmaceuticals Alliances and agreements
02 Jan 2020
14:39 CET
ACACIA PHARMA TR-1: Standard form for notification of major holdings Pharmaceuticals Other subject
06 Dec 2019
13:45 CET
ACACIA PHARMA TR-1: Standard form for notification of major holdings Pharmaceuticals Other subject
13 Nov 2019
07:35 CET
ACACIA PHARMA TR-1: Standard form for notification of major holdings Pharmaceuticals Other subject
31 Oct 2019
13:34 CET
ACACIA PHARMA TR-1: Standard form for notification of major holdings Pharmaceuticals Other subject